Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

7.84
-0.0300-0.38%
Post-market: 7.930.0900+1.15%19:47 EDT
Volume:648.46K
Turnover:5.05M
Market Cap:454.98M
PE:-0.74
High:7.95
Open:7.92
Low:7.61
Close:7.87
Loading ...

Ginkgo Bioworks falls -7.7%

TIPRANKS
·
24 Dec 2024

Applied DNA customer UHKT initiates Phase I clinical trial of UHKT-CAR123-01

TIPRANKS
·
18 Dec 2024

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

ACCESSWIRE
·
18 Dec 2024

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
18 Dec 2024

Applied DNA Sciences Announces Leadership Changes and Restructuring

TIPRANKS
·
18 Dec 2024

Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
18 Dec 2024

Applied DNA Sciences Q4 2024 GAAP EPS $(0.32) Beats $(0.34) Estimate, Sales $813.11K Miss $899.00K Estimate

Benzinga
·
18 Dec 2024

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

ACCESSWIRE
·
18 Dec 2024

Nyse Order Imbalance 43492.0 Shares on Sell Side

THOMSON REUTERS
·
18 Dec 2024

All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy

Zacks
·
18 Dec 2024

Ginkgo Bioworks Awarded $9.4 Million Subcontract to Develop Implantable Bioelectronic Devices

MT Newswires Live
·
17 Dec 2024

Ginkgo Bioworks eligible for $9.4M in partnership for bioelectronic devices

TIPRANKS
·
17 Dec 2024

Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under Arpa-H's React Program

THOMSON REUTERS
·
17 Dec 2024

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

PR Newswire
·
17 Dec 2024

BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family

GlobeNewswire
·
17 Dec 2024

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

ACCESSWIRE
·
16 Dec 2024

Inexpensive Watches Arrive With Design DNA From Piaget and Rolex

Bloomberg
·
16 Dec 2024

Ginkgo Bioworks falls -8.3%

TIPRANKS
·
14 Dec 2024

Stock Track | Ginkgo Bioworks Plummets 5.32% as Baby Switching Allegations Surface at Hospital

Stock Track
·
13 Dec 2024

Stock Track | Ginkgo Bioworks Plummets 5.05% Amid Allegations of Baby Swap at Partner Hospital

Stock Track
·
13 Dec 2024